Minocycline as adjunctive treatment for major depressive disorder: Pooled data from two randomized controlled trials

Translating the HAM-D into the MADRS and vice versa with equipercentile linking

(2018) Stefan Leucht et al.   JOURNAL OF AFFECTIVE DISORDERS

Efficacy and tolerability of minocycline for depression: A systematic review and meta-analysis of clinical trials

(2018) Joshua D. Rosenblat et al.   JOURNAL OF AFFECTIVE DISORDERS

A pilot study of minocycline for the treatment of bipolar depression: Effects on cortical glutathione and oxidative stress in vivo

(2018) James W. Murrough et al.   JOURNAL OF AFFECTIVE DISORDERS

Minocycline promotes post-hemorrhagic neurogenesis via M2 microglia polarization via up-regulation of the TrkB/BDNF pathway in rats

(2018) Miao Hongsheng et al.   JOURNAL OF NEUROPHYSIOLOGY

The Compensatory Immune-Regulatory Reflex System (CIRS) in Depression and Bipolar Disorder

(2018) Michael Maes et al.   MOLECULAR NEUROBIOLOGY

Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial

(2018) Jonathan B. Savitz et al.   Translational Psychiatry

Chronic minocycline treatment reduces the anxiety-like behaviors induced by repeated restraint stress through modulating neuroinflammation

(2018) Liu Haiyan et al.   BRAIN RESEARCH BULLETIN

A Systematic Meta-Review of Predictors of Antidepressant Treatment Outcome in Major Depressive Disorder

(2018) Kelly Perlman et al.   JOURNAL OF AFFECTIVE DISORDERS

Depression

(2018) Gin S Malhi et al.   LANCET

Anti-inflammatory treatments for mood disorders: Systematic review and meta-analysis

(2017) Muhammad I Husain et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Minocycline as an adjunct for treatment-resistant depressive symptoms: A pilot randomised placebo-controlled trial

(2017) Muhammad I Husain et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Comorbid generalized anxiety disorder and its association with quality of life in patients with major depressive disorder

(2017) Yongjie Zhou et al.   Scientific Reports

Developmental minocycline treatment reverses the effects of neonatal immune activation on anxiety- and depression-like behaviors, hippocampal inflammation, and HPA axis activity in adult mice

(2016) Jafar Majidi et al.   BRAIN RESEARCH BULLETIN

Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients

(2016) Hamid Emadi-Kouchak et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Socio-demographic and clinical predictors of non-response/non-remission in treatment resistant depressed patients: A systematic review

(2016) Vera De Carlo et al.   PSYCHIATRY RESEARCH

Gut Microbiota, Bacterial Translocation, and Interactions with Diet: Pathophysiological Links between Major Depressive Disorder and Non-Communicable Medical Comorbidities

(2016) Anastasiya Slyepchenko et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Major depressive disorder

(2016) Christian Otte et al.   Nature Reviews Disease Primers

Efficacy and Acceptability of Pharmacological Treatments for Depressive Disorders in Primary Care: Systematic Review and Network Meta-Analysis

(2015) K. Linde et al.   ANNALS OF FAMILY MEDICINE

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines

(2015) Anthony Cleare et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial

(2015) Muhammad I. Husain et al.   Trials

Protocol and Rationale-The Efficacy of Minocycline as an Adjunctive Treatment for Major Depressive Disorder: A Double Blind, Randomised, Placebo Controlled Trial

(2015) Olivia May Dean et al.   Clinical Psychopharmacology and Neuroscience

Inflamed moods: A review of the interactions between inflammation and mood disorders

(2014) Joshua D. Rosenblat et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review

(2013) G. Fond et al.   ACTA PSYCHIATRICA SCANDINAVICA

Moderators of Outcome in Late-Life Depression: A Patient-Level Meta-Analysis

(2013) J. Craig Nelson et al.   AMERICAN JOURNAL OF PSYCHIATRY

Equations for converting scores between depression scales (MÅDRS, SRS, PHQ-9 and BDI-II): good statistical, but weak idiographic, validity

(2013) Chris J. Hawley et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Novel therapeutic targets in depression: Minocycline as a candidate treatment

(2012) Joanna K. Soczynska et al.   BEHAVIOURAL BRAIN RESEARCH

Minocycline

(2012) Olivia M. Dean et al.   CNS DRUGS

Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment

(2012) Imran B Chaudhry et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Cross-national epidemiology of DSM-IV major depressive episode

(2011) Evelyn Bromet et al.   BMC Medicine

Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression

(2011) Brian Leonard et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Activated Microglia Inhibit Axonal Growth through RGMa

(2011) Mari Kitayama et al.   PLoS One

Prospects for Minocycline Neuroprotection

(2010) Jennifer M. Plane et al.   ARCHIVES OF NEUROLOGY

Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool

(2010) Javier Garcia-Campayo et al.   Health and Quality of Life Outcomes

Antidepressant Drug Effects and Depression Severity

(2010) Jay C. Fournier et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Benefits and pitfalls of pooling datasets from comparable observational studies: combining US and Dutch nursing home studies

(2008) JT van der Steen et al.   PALLIATIVE MEDICINE